Last year, we announced our acquisition by Sanofi, uniting our mission to deliver life-changing medicines to patients worldwide. As we continue on this exciting journey, all future Blueprint Medicines updates will be shared via @Sanofi. Thanks for your support and engagement!
Blueprint Medicines
This account is verified because it's an official organization on X. Learn more@BlueprintMeds
Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that invents life-changing medicines. Read our guidelines: bit.ly/4f72ckr
360 Following 2.8K Followers 1.6K Posts
Latest posts 5
Diverse perspectives are essential to improve understanding of systemic mastocytosis (SM). At our HERO Summit, the SM community came together to share future aspirations and drive change. Hear from Dr. Ala Ebaid, an individual living with SM, and our own Fatima Scipione. @sanofi
1:12
Collaboration and knowledge-sharing are critical for transforming patient care in complex diseases. At #EAACI2026 and #EHA2026, our #BlueCrew engaged with global experts to advance the conversation around systemic mastocytosis (SM) in Europe. @sanofi
Improving the daily burden of disease is a key goal for people living with indolent systemic mastocytosis. At #EAACI2026, we shared long-term findings from our PIONEER study across measures of social/daily functioning and emotional well-being. @sanofi
We’re looking forward to #EHA2026 and #EAACI2026, where we’ll share clinical research across the spectrum of systemic mastocytosis. These data highlight our long-term collaboration with disease experts to advance patient outcomes. Learn more below. @sanofi